MediciNova, Inc.
4875.T
Get informed when a big investor buys or sells
+ FollowMarket Cap$12.06B
Close$
Share Statistics
| Market cap | $12.06 Billion |
|---|---|
| Enterprise Value | $-13,239,677,730.00 |
| Dividend Yield | $- (-) |
| Earnings per Share | $-0.24 |
| Beta | 0.59 |
| Outstanding Shares | 49,221,246 |
Return
| Return on Equity | -15.14% |
|---|---|
| Return on Assets | -13.95% |
| Return on Invested Capital | -8.16% |
Valuation & Multiples
| P/E Ratio | -7 |
|---|---|
| PEG | 23.74 |
| Price to Sales | 40.83 |
| Price to Book Ratio | 0.32 |
| Enterprise Value to Revenue | -42.58 |
| Enterprise Value to EBIT | 4.33 |
| Enterprise Value to Net Income | 2 |
| Total Debt to Enterprise | -0.01 |
| Debt to Equity | 0 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
August 13, 2026
EPS Estimate
$-10.30
Average shareholder expectationRevenue Estimate
$12.17 M
Average shareholder expectationNext Earnings Call
Expected Date
November 12, 2026
EPS Estimate
$-9.84
Average shareholder expectationRevenue Estimate
$7.87 M
Average shareholder expectationInstitutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
ESG Score
No data
About Medicinova Inc
6 employees
CEO: Yuichi Iwaki MediciNova, Inc. is a biopharmaceutical company, which focuses on developing novel therapeutics for the treatment of serious diseases with unmet medical needs and a commercial focus. Its programs include MN-001, MN-166 neurology diseases...